Prognostic value of myocardial perfusion scintigraphy in elderly patients with hypertension: A 10-year follow-up analysis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 10, 2012, Pages 1570-1580

  Fovino, Luca Nai ^a   Saladini, Giorgio ^b   Cervino, Anna Rita ^b   Saladini, Francesca ^a   Gregianin, Michele ^b   Razzolini, Renato ^a   Evangelista, Laura ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Cardiac events; Elderly patients; Hypertension; Myocardial perfusion scintigraphy

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; EVENT FREE SURVIVAL; EXERCISE TEST; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PROGNOSIS; SCINTIGRAPHY; TREADMILL EXERCISE;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; HYPERTENSION; MALE; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS;

EID: 84868250795     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2169-x     Document Type: Article

References (46)

1. Foot DK, Lewis RP, Pearson TA, Beller GA. Demographics and cardiology, 1950-2050. J Am Coll Cardiol 2000;35(4):1067-81. doi:10.1016/s0735-1097(00) 00561-1.
2. American Heart Association. Heart disease and stroke statistics-2009 update. Dallas: American Heart Association; 2009. Available via http://www.americanheart.org.
3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119(3):480-6.
4. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med 1992;327 (14):998-1008. doi:10.1056/nejm199210013271406.
5. Black HR, Cohen JD, Kaplan NM, Ferdinand KC, Chobanian AV, Dustan HP, et al. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157(21):2413-46.
6. Hachamovitch R, Kang X, Amanullah AM, Abidov A, Hayes SW, Friedman JD, et al. Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly. Circulation 2009;120(22):2197-206. doi:10.1161/circulationaha.108.817387.
7. Gargiulo P, Petretta M, Bruzzese D, Cuocolo A, Prastaro M, D'Amore C, et al. Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis. Eur J Nucl Med Mol Imaging 2011;38 (11):2040-9.
8. Valeti US, Miller TD, Hodge DO, Gibbons RJ. Exercise singlephoton emission computed tomography provides effective risk stratification of elderly men and elderly women. Circulation 2005;111(14):1771-6. doi:10.1161/01.cir. 0000160862.36124.8e.
9. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97(6):535-43.
10. Galassi AR, Azzarelli S, Tomaselli A, Giosofatto R, Ragusa A, Musumeci S, et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am J Cardiol 2001;88(2):101-6. doi:10.1016/s0002-9149(01)01601-0.
11. Iskandrian AS, Heo JY, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989;14(6):1477-86. doi:10.1016/0735-1097(89)90385-9.
12. Callaham PR, Froelicher VF, Klein J, Risch M, Dubach P, Friis R. Exercise-induced silent ischemia: age, diabetes mellitus, previous myocardial infarction and prognosis. J Am Coll Cardiol 1989;14 (5):1175-80. doi:10.1016/0735-1097(89)90413-0.
13. Schinkel AFL, Elhendy A, Biagini E, van Domburg RT, Valkema R, Rizello V, et al. Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing. J Nucl Med 2005;46 (1):12-8.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289(19):2560-72. doi:10.1001/jama.289.19.2560.
15. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105(4):539-42.
16. Germano G, Kavanagh PB, Waechter P, Areeda J, Van Kriekinge S, Sharir T, et al. A new algorithm for the quantitation of myocardial perfusion SPECT. I: technical principles and reproducibility. J Nucl Med 2000;41(4):712-9.
17. Sharir T, Germano G, Kang XP, Lewin HC, Miranda R, Cohen I, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001;42(6):831-7.
18. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined -a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36(3):959-69.
19. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97(18):1837-47.
20. Wroblewski EM, Pearl FJ, Hammer WJ, Bove AA. False positive stress tests due to undetected left ventricular hypertrophy. Am J Epidemiol 1982;115(3):412-7.
21. Prisant LM, Frank MJ, Carr AA, von Dohlen TW, Abdulla AM. How can we diagnose coronary heart disease in hypertensive patients? Hypertension 1987;10(5):467-72.
22. Pringle SD, Dunn FG, Lorimer AR, McKillop JH. The role of nuclear cardiology in hypertension. Nucl Med Commun 1994;15 (1):4-8. doi:10.1097/00006231-199401000-00002.
23. DePuey EG, Guertler-Krawczynska E, Perkins JV, Robbins WL, Whelchel JD, Clements SD. Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography. Am J Cardiol 1988;62(4):234-8. doi:10.1016/0002-9149(88)90218-4.
24. Houghton JL, Frank MJ, Carr AA, von Dohlen TW, Prisant LM. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 1990;15(1):43-51.
25. Aguirre JM, Rodriguez E, Ruiz de Azua ER, Urrengoetxea J, Faus JM, Caso R, et al. Segmentary coronary reserve in hypertensive patients with echocardiographic left ventricular hypertrophy, gamma-graphic ischaemia and normal coronary angiography. Eur Heart J 1993;14:25-31.
26. Marcus ML, Wilson RF, White CW. Methods of measurement of myocardial blood flow in patients: a critical review. Circulation 1987;76(2):245-53.
27. López Sendón J. Regional myocardial ischaemia and diastolic dysfunction in hypertensive heart disease. Eur Heart J 1993;14:110-3.
28. Otterstad JE. Ischaemia and left ventricular hypertrophy. Eur Heart J 1993;14:2-6.
29. Parodi O, Neglia D, Palombo C, Sambuceti G, Giorgetti A, Marabotti C, Gallopin M, et al. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension. Circulation 1997;96(3):864-73.
30. Strauer BE, Schwartzkopff B, Kelm M. Assessing the coronary circulation in hypertension. J Hypertens 1998;16(9):1221-33. doi:10.1097/00004872-199816090- 00001.
31. Laine H, Raitakari OT, Niinikoski H, Pitkänen OP, Iida H, Viikari J, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 1998;32(1):147-53. doi:10.1016/s0735-1097(98) 00222-8.
32. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356(8):830-40. doi:10.1056/NEJMra061889.
33. Amanullah AM, Berman DS, Kang XP, Cohen I, Germano G, Friedman JD. Enhanced prognostic stratification of patients with left ventricular hypertrophy with the use of single-photon emission computed tomography. Am Heart J 2000;140(3):456-62. doi:10.1067/mhj.2000.108833.
34. Elhendy A, Schinkel AFL, Van Domburg RT, Bax JJ, Poldermans D. Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion. J Hypertens 2003;21(10):1945-51. doi:10.1097/01.hjh.0000084763.37215.ae.
35. Shaw L, Chaitman BR, Hilton TC, Stocke K, Younis LT, Caralis DG, et al. Prognostic value of dipyridamole thallium-201 imaging in elderly patients. J Am Coll Cardiol 1992;19(7):1390-8.
36. 7Hachamovitch R, Berman DS, Kiat H, Cohen I, Lewin H, Amanullah A, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997;80(4):426-33.
37. Astarita C, Pálinkás A, Nicolai E, Maresca FS, Varga A, Picano E. Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test. J Hypertens 2001;19 (3):495-502. doi:10.1097/00004872- 200103000-00018.
38. Thomas GS, Miyamoto MI. Is a revision of the "nuclear cardiology warranty" in order? J Nucl Cardiol 2003;10(3):329-32. doi:10.1016/s1071- 3581(03)00439-2.
39. Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans; what is the warranty period of a normal scan? J Am Coll Cardiol 2003;41 (8):1329-40. doi:10.1016/s0735-1097(03)00125-6.
40. Thompson RC, Holmes DR, Gersh BJ, Mock MB, Bailey KR. Percutaneous transluminal coronary angioplasty in the elderly: early and long-term results. J Am Coll Cardiol 1991;17(6):1245-50.
41. Wang FP, Amanullah AM, Kiat H, Friedman JD, Berman DS. Diagnostic efficacy of stress technetium 99m-labeled sestamibi myocardial perfusion single-photon emission computed tomography in detection of coronary artery disease among patients over age 80. J Nucl Cardiol 1995;2(5):380-8. doi:10.1016/s1071-3581 (05)80025-x.
42. Batchelor WB, Anstrom KJ, Muhlbaier LH, Grosswald R, Weintraub WS, O'Neill WW, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol 2000;36 (3):723-30. doi:10.1016/s0735-1097(00)00777-4.
43. Alexander KP, Anstrom KJ, Muhlbaier LH, Grosswald RD, Smith PK, Jones RH, et al. Outcomes of cardiac surgery in patients age≥ 80 years: results from the National Cardiovascular Network. J Am Coll Cardiol 2000;35(3):731-8. doi:10.1016/s0735-1097(99)00606-3.
44. Acampa W, Petretta M, Evangelista L, Daniele S, Xhoxhi E, De Rimini ML, et al. Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial. Eur J Nucl Med Mol Imaging 2012;39(3):387-95. doi:10.1007/s00259-011-1983-x.
45. Hilton TC, Shaw LJ, Chaitman BR, Stocke KS, Goodgold HM, Miller DD. Prognostic significance of exercise thallium-201 testing in patients aged greater than or equal to 70 years with known or suspected coronary artery disease. Am J Cardiol 1992;69(1):45-50. doi:10.1016/0002-9149(92)90674-n.
46. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93(5):905-14.